Anthropic has reportedly launched its own drug discovery activities and acquired a biotech company with 1 employee. It has also been reported to be planning research into treatments for rare pediatric diseases.
Anthropic has indicated its intention to begin its own drug discovery activities and says it will strengthen its initiatives in the drug discovery field. While the article does not provide details on the specific methods or target diseases, it reports that the company has begun activities as part of its drug discovery efforts.
The article states that the acquisition target was a biotech company with 1 employee. Details such as the acquisition price, terms and background have not been disclosed.
The stated purpose of the acquisition is to advance research into treatments for rare pediatric diseases. The primary focus is said to be advancing research into treatments for rare diseases affecting children.